Summary

The global Advanced visualization market is projected to reach USD 6.55 billion by 2029 from USD 3.78 billion in 2024, at a CAGR of 11.7% during the forecast period. The market is expected to grow as a result of the increasing investments & fundings by public-private organizations, surging demand for technologically advanced visualization solutions for various applications across the industry, such as, cardiology, radiology, neurology, oncology, among others. Moreover, the market has experienced growth due to the need for improved imaging techniques across healthcare industry. However, insufficient IT infrastructure, and reluctance towards adoption of advanced visualization solutions in emerging economies are some of the factors that are expected to pose a challenge to the market growth.

“Cloud-based subsegment, under the advanced visualization software segment is expected to register highest growth during the forecast period.”
The advanced visualization software segment is sub-segmented into on-premise and cloud-based. In 2023, the cloud-based segment is expected to register the highest growth during the forecast period. The growth of the cloud segment is attributed to the ample number of advantages offered by this model, such as the seamless integration of data from various silos, unlimited user access from remote locations, low maintenance costs, high security, privacy, easy accessibility, no upfront capital investment for hardware, and extreme capacity flexibility and optimized resource utilization. Moreover, the increasing demand for remote healthcare services and telemedicine solutions has accelerated the adoption of cloud technologies that facilitate easy access to imaging tools and data sharing among healthcare professionals, further contributing to the segment's growth.

“Hospitals & Ambulatory Surgical Centers is projected to dominate the market in the advanced visualization market, by end user during the forecast period.”
The hospitals & ambulatory surgical centers, diagnostic & imaging centers, academic & research centers, and other end users make up the end user segments of the advanced visualization market. In 2023, the hospitals & ambulatory surgical centers accounted for a significant share of the advanced visualization market, by end user. The segment is also expected to register paramount growth during the forecast period. The prominent position & high growth of this segment is due to the increasing complexity of imaging data, demand for precise diagnostics & surgical planning, rise in minimally-invasive procedures, and the need for interoperability with existing systems. Moreover, the push for personalized medicine and precision therapeutics, the integration of Al and machine learning further strengthens the value of advanced visualization in the provider industry.

“Asia Pacific is expected to register highest market growth during the forecast period.”
The advanced visualization market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific region is expected to register highest growth during the forecast period. The high growth of this region is attributed to the the presence of a large and growing patient population in the region, the increasing need for innovative therapies, the emergence of big data in healthcare, increasing spending on HCIT infrastructure, and the shifting focus of various market players on emerging countries in the region. Government initiatives to promote the adoption of digital & technologically enabled solutions across healthcare industry, and significant focus on integrating sophisticated technologies across the workflows also contributes to the growth.

The break-down of primary participants is as mentioned below:
• By Company Type - Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
• By Designation - Directors: 30%, Manager: 34%, and Others: 36%
• By Region - North America: 40%, Europe: 28%, Asia Pacific: 20%, Latin America: 7% and Middle East & Africa: 5%

List of Companies Profiled in the Report
o Agfa-Gevaert Group (Belgium)
o Canon Medical Systems Corporation (Japan)
o Fujifilm Holdings Corporation (Japan)
o GE Healthcare (US)
o Koninklijke Philips N.V. (Netherlands)
o Siemens Healthineers AG (Germany)
o Stryker (US)
o Change Healthcare (US)
o TeraRecon (US)
o Ziosoft (Japan)
o Pro Medicus, Ltd (Australia)
o Carestream Health (US)
o Fovia, Inc. (US)
o 4DMedical (Australia)
o Synopsys, Inc. (US)
o Novarad (US)
o AnalyzeDirect, Inc. (US)
o Syntermed Inc. (Netherlands)
o Pie Medical Imaging B.V. (Netherlands)
o Infinitt Healthcare Co., Ltd. (US)
o Biotronics 3D (UK)
o Minnovaa Innovations Oü (Estonia)
o Postdicom (Netherlands)
o CitiusTech Inc (US)
o Ceevra, Inc. (US)
Research Coverage:
The report analyzes the advanced visualization market and aims to estimate the market size and future growth potential of various market segments, based on offering, solution type, imaging modality, applicarion, end user, and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total advanced visualization market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
• Analysis of key drivers (booming geriatric population, growing advancements in picture archiving and communication systems and advanced visualization, rising investments by government and private organizations, increasing need for early disease diagnosis), restraints (limited availability of reimbursements, high deployment cost of advanced visualization tools), opportunities (expanding modernization efforts in emerging economies, growing adoption of artificial intelligence and machine learning, increasing establishment of hospitals and diagnostic imaging centers), challenges (shortage of skilled personnel, declining budget allocation for health services) are factors contributing the growth of the advanced visualization market.
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the advanced visualization market.
• Market Development: Comprehensive information on the lucrative emerging markets, type of solution, component, deployment model, industry, and region.
• Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the advanced visualization market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global advanced visualization market such as Agfa-Gevaert Group (Belgium), Canon Medical Systems Corporation (Japan), Fujifilm Holdings Corporation (Japan), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands).

ページTOPに戻る

Table of Contents

1 INTRODUCTION 30
1.1 STUDY OBJECTIVES 30
1.2 MARKET DEFINITION 30
1.3 STUDY SCOPE 31
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 31
1.3.2 INCLUSIONS AND EXCLUSIONS 32
1.3.3 YEARS CONSIDERED 33
1.4 CURRENCY CONSIDERED 33
1.5 STAKEHOLDERS 34
1.6 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
2.1.1 SECONDARY DATA 37
2.1.1.1 Key data from secondary sources 38
2.1.2 PRIMARY DATA 38
2.1.2.1 Key industry insights 40
2.2 MARKET SIZE ESTIMATION 41
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 46
2.4 MARKET SHARE ESTIMATION 47
2.5 RESEARCH ASSUMPTIONS 47
2.6 RESEARCH LIMITATIONS 47
2.6.1 METHODOLOGY-RELATED LIMITATIONS 47
2.6.2 SCOPE-RELATED LIMITATIONS 47
2.7 RISK ASSESSMENT 48
3 EXECUTIVE SUMMARY 49
4 PREMIUM INSIGHTS 55
4.1 ADVANCED VISUALIZATION MARKET OVERVIEW 55
4.2 ASIA PACIFIC: ADVANCED VISUALIZATION MARKET, BY OFFERING AND COUNTRY 56
4.3 ADVANCED VISUALIZATION MARKET, BY COUNTRY 57
4.4 ADVANCED VISUALIZATION MARKET: REGIONAL MIX 57
4.5 ADVANCED VISUALIZATION MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS 58
 
5 MARKET OVERVIEW 59
5.1 INTRODUCTION 59
5.2 MARKET DYNAMICS 59
5.2.1 DRIVERS 60
5.2.1.1 Booming geriatric population 60
5.2.1.2 Growing advancements in picture archiving and communication systems and advanced visualization 62
5.2.1.3 Rising investments by government and private organizations 63
5.2.1.4 Increasing need for early disease diagnosis 64
5.2.2 RESTRAINTS 64
5.2.2.1 Limited availability of reimbursements 64
5.2.2.2 High deployment cost of advanced visualization tools 65
5.2.3 OPPORTUNITIES 65
5.2.3.1 Expanding modernization efforts in emerging economies 65
5.2.3.2 Growing adoption of artificial intelligence and machine learning 66
5.2.3.3 Increasing establishment of hospitals and diagnostic imaging centers 67
5.2.4 CHALLENGES 67
5.2.4.1 Shortage of skilled personnel 67
5.2.4.2 Declining budget allocation for health services 68
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 68
5.4 INDICATIVE PRICING ANALYSIS 69
5.4.1 INDICATIVE SELLING PRICE, BY OFFERING 70
5.4.2 INDICATIVE SELLING PRICE, BY REGION 71
5.5 VALUE CHAIN ANALYSIS 72
5.6 ECOSYSTEM ANALYSIS 74
5.7 INVESTMENT AND FUNDING SCENARIO 76
5.8 TECHNOLOGY ANALYSIS 76
5.8.1 KEY TECHNOLOGIES 76
5.8.1.1 Machine learning and artificial intelligence 76
5.8.1.2 Augmented reality and virtual reality 76
5.8.1.3 Cloud computing 77
5.8.2 COMPLEMENTARY TECHNOLOGIES 77
5.8.2.1 Bioinformatics tools 77
5.8.2.2 Big data analytics 77
5.8.2.3 Internet of things 78
5.8.3 ADJACENT TECHNOLOGIES 78
5.8.3.1 Blockchain 78
5.8.3.2 Quantum computing 78
 
5.9 INDUSTRY TRENDS 79
5.9.1 INTEGRATION OF ADVANCED VISUALIZATION SOLUTIONS WITH DATA-SHARING MODALITIES 79
5.9.2 INTEGRATION OF ADVANCED VISUALIZATION SOLUTIONS WITH PICTURE ARCHIVING AND COMMUNICATION SYSTEMS 79
5.10 PATENT ANALYSIS 80
5.11 KEY CONFERENCES AND EVENTS, 2024–2025 82
5.12 CASE STUDY ANALYSIS 83
5.12.1 ENHANCED LEARNING EXPERIENCE USING ADVANCED VISUALIZATION TECHNIQUES 83
5.12.2 IMPROVED DETERMINATION AND SIMULATION OF LYMPH NODE
BY 3D RECONSTRUCTION 83
5.12.3 ENHANCED DECISION-MAKING AND TRACKING OF TUMOR PROGRESSION WITH VISUALIZATION TOOLS 84
5.13 REGULATORY LANDSCAPE 84
5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
5.13.2 REGULATORY ANALYSIS 87
5.14 PORTER’S FIVE FORCES ANALYSIS 90
5.14.1 THREAT OF NEW ENTRANTS 91
5.14.2 THREAT OF SUBSTITUTES 91
5.14.3 BARGAINING POWER OF SUPPLIERS 91
5.14.4 BARGAINING POWER OF BUYERS 91
5.14.5 INTENSITY OF COMPETITIVE RIVALRY 92
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 92
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 92
5.15.2 BUYING CRITERIA 93
5.16 END-USER ANALYSIS 94
5.16.1 UNMET NEEDS 94
5.16.2 END-USER EXPECTATIONS 96
5.17 ADVANCED VISUALIZATION BUSINESS MODELS 97
5.17.1 SUBSCRIPTION-BASED MODEL 97
5.17.2 SAAS MODEL 97
5.17.3 ENTERPRISE LICENSING 97
5.17.4 FREEMIUM MODEL 97
5.17.5 CONSULTING SERVICES MODEL 97
5.17.6 PARTNERSHIP/REVENUE-SHARING MODEL 97
5.17.7 HYBRID MODEL 98
5.17.8 SERVICE MODEL 98
5.18 IMPACT OF AI/GENERATIVE AI ON ADVANCED VISUALIZATION MARKET 98
5.18.1 INTRODUCTION 98
5.18.2 MARKET POTENTIAL OF ADVANCED VISUALIZATION 98
5.18.3 AI USE CASES IN ADVANCED VISUALIZATION 99
5.18.3.1 Key use cases of AI 99
5.18.3.2 Potential use cases of gen AI 100
5.18.4 CASE STUDY 100
5.18.5 IMPACT OF GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 101
5.18.5.1 Diagnostic procedures 101
5.18.5.2 Personalized treatment 102
5.18.5.3 Predictive patient care 102
5.18.5.4 Operational efficiency 102
5.18.5.5 Healthcare imaging 103
5.18.6 USER READINESS AND IMPACT ASSESSMENT 103
5.18.6.1 User readiness 103
5.18.6.1.1 Hospitals & ambulatory surgical centers 103
5.18.6.1.2 Diagnostic & imaging centers 103
5.18.6.1.3 Academic & research centers 104
5.18.6.2 Impact assessment 104
5.18.6.2.1 User A: Hospitals & ambulatory surgical centers 104
5.18.6.2.1.1 Implementation 104
5.18.6.2.1.2 Impact 105
5.18.6.2.2 User B: Diagnostic & imaging centers 105
5.18.6.2.2.1 Implementation 105
5.18.6.2.2.2 Impact 105
5.18.6.2.3 User C: Academic & research centers 106
5.18.6.2.3.1 Implementation 106
5.18.6.2.3.2 Impact 106
6 ADVANCED VISUALIZATION MARKET, BY OFFERING 107
6.1 INTRODUCTION 108
6.2 SERVICES 108
6.2.1 IMPLEMENTATION SERVICES 110
6.2.1.1 Rising installation of advanced visualization solutions in hospitals & diagnostic centers to sustain growth 110
6.2.2 CONSULTING/OPTIMIZATION SERVICES 111
6.2.2.1 Increasing adoption of enhanced workflow practices to support growth 111
6.2.3 TRAINING & EDUCATION SERVICES 112
6.2.3.1 Growing adoption of technologically advanced 3D imaging software to drive market 112
6.2.4 POST-SALES & MAINTENANCE SERVICES 113
6.2.4.1 Increasing availability of advanced visualization solutions to propel market 113
6.3 SOFTWARE 114
6.3.1 ON-PREMISE SOFTWARE 116
6.3.1.1 Rising focus on enhanced patient care and operational efficiency to augment growth 116
 
6.3.2 CLOUD-BASED SOFTWARE 117
6.3.2.1 Increasing demand for remote healthcare services and telemedicine to accelerate growth 117
6.4 HARDWARE 118
6.4.1 GROWING DEMAND FOR HIGH-QUALITY IMAGING IN SPECIALIZED FIELDS TO BOOST MARKET 118
7 ADVANCED VISUALIZATION MARKET, BY SOLUTION TYPE 120
7.1 INTRODUCTION 121
7.2 ENTERPRISE-WIDE THIN CLIENT-BASED SOLUTIONS 121
7.2.1 NEED TO IMPROVE DIAGNOSTIC CAPABILITIES ACROSS HEALTHCARE FACILITIES TO DRIVE MARKET 121
7.3 STANDALONE WORKSTATION-BASED SOLUTIONS 123
7.3.1 INCREASING COMPLEXITY OF MEDICAL IMAGING DATA TO FACILITATE GROWTH 123
8 ADVANCED VISUALIZATION MARKET, BY IMAGING MODALITY 125
8.1 INTRODUCTION 126
8.2 MAGNETIC RESONANCE IMAGING 126
8.2.1 INCREASING INSTALLATIONS OF MAGNETIC RESONANCE IMAGING MACHINES TO SUSTAIN GROWTH 126
8.3 COMPUTED TOMOGRAPHY 127
8.3.1 RISING NEED FOR PRECISE ASSESSMENT OF COMPLEX ANATOMICAL STRUCTURES TO DRIVE MARKET 127
8.4 POSITRON EMISSION TOMOGRAPHY 129
8.4.1 GROWING ADOPTION OF ADVANCED VISUALIZATION IN ONCOLOGY, NEUROLOGY, AND CARDIOLOGY TO BOOST MARKET 129
8.5 ULTRASOUND 130
8.5.1 GROWING PREFERENCE OF HEALTHCARE PROFESSIONALS FOR ADVANCED ULTRASOUND TO PROPEL MARKET 130
8.6 RADIOTHERAPY 131
8.6.1 RISING DEMAND FOR PERSONALIZED AND PRECISE CANCER TREATMENT TO PROMOTE GROWTH 131
8.7 NUCLEAR MEDICINE 132
8.7.1 NEED TO ASSESS HEALTH AND FUNCTIONING OF CRITICAL ORGANS TO SUPPORT GROWTH 132
8.8 OTHER IMAGING MODALITIES 133
9 ADVANCED VISUALIZATION MARKET, BY APPLICATION 135
9.1 INTRODUCTION 136
9.2 RADIOLOGICAL/INTERVENTIONAL RADIOLOGICAL APPLICATIONS 136
9.2.1 ONGOING TREND OF PROCESS AUTOMATION AND WORKFLOW DIGITIZATION TO AUGMENT GROWTH 136
9.3 CARDIOLOGICAL APPLICATIONS 138
9.3.1 GROWING INCIDENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET 138
9.4 ORTHOPEDIC APPLICATIONS 139
9.4.1 INCREASING ADVANCEMENTS IN HOLOGRAPHIC TECHNOLOGY AND VIRTUAL REALITY TO EXPEDITE GROWTH 139
9.5 ONCOLOGICAL APPLICATIONS 140
9.5.1 RISING INCIDENCE OF CANCER TO CONTRIBUTE TO SEGMENT GROWTH 140
9.6 VASCULAR APPLICATIONS 141
9.6.1 NEED FOR PRECISE IMAGING TO SUSTAIN GROWTH 141
9.7 NEUROLOGICAL APPLICATIONS 142
9.7.1 GROWING ADVANCEMENTS IN NEUROIMAGING TECHNIQUES TO FUEL MARKET 142
9.8 OTHER APPLICATIONS 144
10 ADVANCED VISUALIZATION MARKET, BY END USER 145
10.1 INTRODUCTION 146
10.2 HOSPITALS & AMBULATORY SURGICAL CENTERS 146
10.2.1 HIGH ADOPTION RATE OF DIAGNOSTIC PROCEDURES FOR EARLY DISEASE DETECTION TO CONTRIBUTE TO GROWTH 146
10.3 DIAGNOSTIC & IMAGING CENTERS 147
10.3.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO FAVOR GROWTH 147
10.4 ACADEMIC & RESEARCH CENTERS 149
10.4.1 GROWING NUMBER OF FUNDS AND GRANTS FOR RESEARCH ACTIVITIES TO DRIVE MARKET 149
10.5 OTHER END USERS 150
11 ADVANCED VISUALIZATION MARKET, BY REGION 151
11.1 INTRODUCTION 152
11.2 NORTH AMERICA 152
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 153
11.2.2 US 158
11.2.2.1 Continuous technological advancements in diagnostic imaging modalities to promote growth 158
11.2.3 CANADA 161
11.2.3.1 Increasing prevalence of heart ailments to expedite growth 161
11.3 EUROPE 164
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 164
11.3.2 GERMANY 168
11.3.2.1 Rapid growth of diagnostic imaging research activities and outsourcing of testing to boost market 168
11.3.3 UK 172
11.3.3.1 Rising acceptance of advanced diagnostic imaging techniques to aid growth 172
11.3.4 FRANCE 174
11.3.4.1 Easy accessibility to diagnostic assay procedures and availability of low-cost surgical facilities to spur growth 174
11.3.5 SPAIN 178
11.3.5.1 Increasing access to advanced cancer screening programs to stimulate growth 178
11.3.6 ITALY 181
11.3.6.1 Growing adoption of digitized diagnostic techniques to fuel market 181
11.3.7 REST OF EUROPE 184
11.4 ASIA PACIFIC 188
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 188
11.4.2 JAPAN 193
11.4.2.1 Favorable reimbursement system and growing access to healthcare systems to propel market 193
11.4.3 CHINA 197
11.4.3.1 Changing lifestyle and growing purchasing power to accelerate growth 197
11.4.4 INDIA 200
11.4.4.1 Rising trend of medical tourism to augment growth 200
11.4.5 REST OF ASIA PACIFIC 203
11.5 LATIN AMERICA 206
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 206
11.5.2 BRAZIL 210
11.5.2.1 Free and universal public health system to contribute to market growth 210
11.5.3 MEXICO 212
11.5.3.1 Growing adoption of advanced devices to fuel market 212
11.5.4 REST OF LATIN AMERICA 215
11.6 MIDDLE EAST & AFRICA 219
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 219
11.6.2 GCC COUNTRIES 223
11.6.2.1 Growing focus on improving healthcare services and infrastructure to drive market 223
11.6.3 REST OF MIDDLE EAST & AFRICA 226
12 COMPETITIVE LANDSCAPE 230
12.1 OVERVIEW 230
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, JANUARY 2021–SEPTEMBER 2024 230
12.3 REVENUE ANALYSIS, 2019–2023 235
12.4 MARKET SHARE ANALYSIS, 2023 235
12.5 COMPANY VALUATION AND FINANCIAL METRICS 238
12.6 BRAND/PRODUCT COMPARISON 239
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 240
12.7.1 STARS 240
12.7.2 EMERGING LEADERS 240
12.7.3 PERVASIVE PLAYERS 240
12.7.4 PARTICIPANTS 240
12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 242
12.7.5.1 Company footprint 242
12.7.5.2 Application footprint 243
12.7.5.3 Solution type footprint 244
12.7.5.4 Imaging modality 245
12.7.5.5 Component footprint 246
12.7.5.6 End-user footprint 247
12.7.5.7 Region footprint 248
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 249
12.8.1 PROGRESSIVE COMPANIES 249
12.8.2 RESPONSIVE COMPANIES 249
12.8.3 DYNAMIC COMPANIES 249
12.8.4 STARTING BLOCKS 249
12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 251
12.8.5.1 Detailed list of key startups/SMEs 251
12.8.5.2 Competitive benchmarking of key startups/SMEs 252
12.9 COMPETITIVE SCENARIO 254
12.9.1 PRODUCT LAUNCHES AND UPGRADES 254
12.9.2 DEALS 256
13 COMPANY PROFILES 257
13.1 KEY PLAYERS 257
13.1.1 AGFA-GEVAERT GROUP 257
13.1.1.1 Business overview 257
13.1.1.2 Products/Solutions/Services offered 258
13.1.1.3 Recent developments 259
13.1.1.3.1 Deals 259
13.1.1.4 MnM view 260
13.1.1.4.1 Right to win 260
13.1.1.4.2 Strategic choices 261
13.1.1.4.3 Weaknesses and competitive threats 261
13.1.2 CANON MEDICAL SYSTEMS CORPORATION 262
13.1.2.1 Business overview 262
13.1.2.2 Products/Solutions/Services offered 263
13.1.2.3 MnM view 264
13.1.2.3.1 Right to win 264
13.1.2.3.2 Strategic choices 264
13.1.2.3.3 Weaknesses and competitive threats 265
 
13.1.3 FUJIFILM HOLDINGS CORPORATION 266
13.1.3.1 Business overview 266
13.1.3.2 Products/Solutions/Services offered 267
13.1.3.3 Recent developments 269
13.1.3.3.1 Product launches and upgrades 269
13.1.3.3.2 Deals 269
13.1.4 GE HEALTHCARE 270
13.1.4.1 Business overview 270
13.1.4.2 Products/Solutions/Services offered 271
13.1.4.3 Recent developments 272
13.1.4.3.1 Product launches and upgrades 272
13.1.4.3.2 Deals 273
13.1.4.4 MnM view 273
13.1.4.4.1 Right to win 273
13.1.4.4.2 Strategic choices 273
13.1.4.4.3 Weaknesses and competitive threats 273
13.1.5 SIEMENS HEALTHINEERS AG 274
13.1.5.1 Business overview 274
13.1.5.2 Products/Solutions/Services offered 275
13.1.5.3 MnM view 276
13.1.5.3.1 Right to win 276
13.1.5.3.2 Strategic choices 276
13.1.5.3.3 Weaknesses and competitive threats 276
13.1.6 KONINKLIJKE PHILIPS N.V. 277
13.1.6.1 Business overview 277
13.1.6.2 Products/Solutions/Services offered 278
13.1.6.3 Recent developments 279
13.1.6.3.1 Product launches and upgrades 279
13.1.6.3.2 Deals 280
13.1.6.4 MnM view 281
13.1.6.4.1 Right to win 281
13.1.6.4.2 Strategic choices 281
13.1.6.4.3 Weaknesses and competitive threats 281
13.1.7 STRYKER 282
13.1.7.1 Business overview 282
13.1.7.2 Products/Solutions/Services offered 283
13.1.7.3 Recent developments 284
13.1.7.3.1 Product launches and upgrades 284
13.1.7.3.2 Deals 284
 
13.1.8 CHANGE HEALTHCARE (UNITEDHEALTH GROUP) 285
13.1.8.1 Business overview 285
13.1.8.2 Products/Solutions/Services offered 286
13.1.9 TERARECON 287
13.1.9.1 Business overview 287
13.1.9.2 Products/Solutions/Services offered 287
13.1.9.3 Recent developments 288
13.1.9.3.1 Product launches and upgrades 288
13.1.9.3.2 Deals 288
13.1.10 ZIOSOFT 290
13.1.10.1 Business overview 290
13.1.10.2 Products/Solutions/Services offered 290
13.1.10.3 Recent developments 291
13.1.10.3.1 Product launches and upgrades 291
13.1.11 PRO MEDICUS, LTD. 292
13.1.11.1 Business overview 292
13.1.11.2 Products/Solutions/Services offered 293
13.1.11.3 Recent developments 293
13.1.11.3.1 Contracts 293
13.1.12 CARESTREAM HEALTH 295
13.1.12.1 Business overview 295
13.1.12.2 Products/Solutions/Services offered 295
13.1.12.3 Recent developments 296
13.1.12.3.1 Product launches and upgrades 296
13.1.13 FOVIA, INC. 297
13.1.13.1 Business overview 297
13.1.13.2 Products/Solutions/Services offered 297
13.1.14 4DMEDICAL 298
13.1.14.1 Business overview 298
13.1.14.2 Products/Solutions/Services offered 299
13.1.14.3 Recent developments 299
13.1.14.3.1 Deals 299
13.1.15 SYNOPSYS, INC. 300
13.1.15.1 Business overview 300
13.1.15.2 Products/Solutions/Services offered 301
13.1.15.3 Recent developments 302
13.1.15.3.1 Deals 302
13.1.16 NOVARAD 303
13.1.16.1 Business overview 303
13.1.16.2 Products/Solutions/Services offered 303
 
13.1.17 ANALYZEDIRECT, INC. 305
13.1.17.1 Business overview 305
13.1.17.2 Products/Solutions/Services offered 305
13.1.18 SYNTERMED INC. 306
13.1.18.1 Business overview 306
13.1.18.2 Products/Solutions/Services offered 306
13.1.19 PIE MEDICAL IMAGING B.V. 307
13.1.19.1 Business overview 307
13.1.19.2 Products/Solutions/Services offered 307
13.1.19.3 Recent developments 308
13.1.19.3.1 Product launches and upgrades 308
13.1.19.3.2 Deals 308
13.1.20 INFINITT HEALTHCARE CO., LTD. 309
13.1.20.1 Business overview 309
13.1.20.2 Products/Solutions/Services offered 309
13.1.20.3 Recent developments 310
13.1.20.3.1 Deals 310
13.2 OTHER PLAYERS 311
13.2.1 BIOTRONICS 3D 311
13.2.2 MINNOVAA INNOVATIONS OÜ 312
13.2.3 POSTDICOM 313
13.2.4 CITIUSTECH INC 314
13.2.5 CEEVRA, INC. 315
14 APPENDIX 316
14.1 DISCUSSION GUIDE 316
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 321
14.3 CUSTOMIZATION OPTIONS 323
14.4 RELATED REPORTS 323
14.5 AUTHOR DETAILS 324